Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy, study suggests
For the first time, scientists have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy. Initial results of the ongoing, small clinical trial of three patients with glioblastoma showed that two patients survived longer than predicted if they had not been given the transplants, and a third patient remains alive with no disease progression almost three years after treatment.
- Gene-modified stem cells help protect bone marrow from toxic side effects of chemotherapySat, 21 May 2011, 6:02:01 EDT
- Most patients recover from 'chemo-brain' by 5 years after stem cell transplantTue, 3 May 2011, 11:34:09 EDT
- New half-match bone marrow transplant procedure yields promising outcomes for cancer patientsThu, 1 Sep 2011, 18:35:19 EDT
- Half-matched transplants widen pool of donors for leukemia and lymphomaThu, 7 Jul 2011, 12:09:14 EDT
- Older age doesn't affect survival after bone marrow transplantMon, 8 Dec 2008, 9:52:30 EST